Question 1

What are the potential side effects of macitentan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

Question 2

How does macitentan compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the study involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my health be closely monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction clinical trial (NCT02070991). Contact the study team or your healthcare provider for specific answers.

What this study is about